Navigation Links
EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
Date:10/29/2008


-- EMD Serono to acquire US rights in tesamorelin, a Phase III compound

being investigated for the treatment of excess abdominal fat in HIV

patients with lipodystrophy

-- Theratechnologies to receive up to US$215 million plus increasing

-- royalties on net sales in the US

-- Merck KGaA, Darmstadt, Germany, of which EMD Serono is an affiliate, to

make equity investment in Theratechnologies

-- EMD Serono acquires option to participate in future tesamorelin

-- indications in the US

-- EMD Serono contributes extensive commercialization and marketing

knowledge for tesamorelin launch and will assist in tesamorelin FDA

approval process

-- EMD Serono delivers on business development strategy in the US

-- marketplace

ROCKLAND, Mass., Oct. 29 /PRNewswire/ -- EMD Serono Inc., an affiliate of Merck KGaA , Darmstadt Germany, and Theratechnologies (TSX:TH) announced today they have entered into a collaboration and licensing agreement for the exclusive commercialization rights, by EMD Serono, Inc., to tesamorelin in the United States for the treatment of excess abdominal fat in HIV patients with lipodystrophy. Theratechnologies retains all tesamorelin commercialization rights outside of the US.

"We are excited about this collaboration and believe that EMD Serono's scientific expertise, established physician relationships and highly trained specialty sales force coupled with Theratechnologies' regulatory experience and understanding of HIV-associated disorders will ultimately benefit patients. Together, I am confident that our teams can maximize the potential of tesamorelin in the marketplace and we are looking forward to the opportunities for tesamorelin in the US once approved," said Mr. Fereydoun Firouz, President and CEO of EMD Serono, Inc. "This partnership reinforces our commitment to our endocrinology franchise in the US and specifically to
'/>"/>

SOURCE EMD Serono, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
2. InterPage L.P. Announces New Enhancements to Enterprise 101 Messaging Solution
3. ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call
4. Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information
5. Sonic Innovations Announces Results for Third Quarter 2008
6. WellPoint Announces Appearances at Upcoming Conferences
7. Beckman Coulter Announces Third Quarter 2008 Results
8. Align Technology Announces Third Quarter Fiscal 2008 Results
9. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
10. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
11. Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com : Supports first randomized, placebo-controlled clinical trial in the U.S. using autologous adult stem cells to treat patients with end-stage Critical Limb Ischemia
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production 13617 1Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production 13617 2Video Gamers Older Than You Think 54770 1Video Gamers Older Than You Think 54770 2Video Gamers Older Than You Think 54770 3Video Gamers Older Than You Think 54770 4 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 1 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 2 26quot 3BMed Records to Go 26quot 3B Stores Document and Image Files of Medical Facilities for Emergency Viewing 54765 3